Cargando…
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified as prognostic biomarkers and potential therapeutic targets in chronic myeloid leukemia (CML) and multiple solid tumors. In the present study, we analyzed the expression of 19S proteasome subunits in acute myeloid leu...
Autores principales: | Lara, Joshua J., Bencomo-Alvarez, Alfonso E., Gonzalez, Mayra A., Olivas, Idaly M., Young, James E., Lopez, Jose L., Velazquez, Vanessa V., Glovier, Steven, Keivan, Mehrshad, Rubio, Andres J., Dang, Sara K., Solecki, Jonathan P., Allen, Jesse C., Tapia, Desiree N., Tychhon, Boranai, Astudillo, Gonzalo E., Jordan, Connor, Chandrashekar, Darshan S., Eiring, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740165/ https://www.ncbi.nlm.nih.gov/pubmed/36498916 http://dx.doi.org/10.3390/ijms232314586 |
Ejemplares similares
-
The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer
por: Tychhon, Boranai, et al.
Publicado: (2023) -
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021) -
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
por: Bencomo-Alvarez, Alfonso E., et al.
Publicado: (2021) -
The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016) -
UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017)